Article
Microbiome and pancreatic cancer: time to think about chemotherapy
18 Jul 2024
Abstract excerpt
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer characterized by late diagnosis, rapid progression, and a high mortality rate. Its complex biology, characterized by a dense, stromal tumor environment with an immunosuppressive milieu, contributes to resistance against standard treatments like chemotherapy and radiation. This comprehensive review explores the dynamic role of the microbiome in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
